HIF-1: A target for cancer, ischemia and inflammation - Too good to be true?

Cell Cycle

Volumn 3, Issue 2, 2004, Pages 154-155

  Melillo, Giovanni ^a,b  

^a SAIC FREDERICK INC   (United States)

^b NATIONAL CANCER INSTITUTE   (United States)

Author keywords

Cancer therapeutics; HIF 1; Hypoxia; Metastasis; Molecular targets; Tumor microenvironment

Indexed keywords

CARBONATE DEHYDRATASE; CARBONATE DEHYDRATASE IX; DNA TOPOISOMERASE; HYPOXIA INDUCIBLE FACTOR 1; HYPOXIA INDUCIBLE FACTOR 1ALPHA; INDUCIBLE NITRIC OXIDE SYNTHASE; UNCLASSIFIED DRUG; DNA BINDING PROTEIN; HELIX LOOP HELIX PROTEIN; NUCLEAR PROTEIN; TRANSCRIPTION FACTOR;

CANCER; CANCER GROWTH; CELL DEATH; CELL INFILTRATION; CELL INVASION; CELL MIGRATION; CELL PH; EDITORIAL; ENZYME INHIBITION; GENE TARGETING; GLYCOLYSIS; IMMUNOCOMPETENT CELL; INFLAMMATION; INFLAMMATORY CELL; ISCHEMIA; TRANSCRIPTION REGULATION; ANIMAL; CELL MOTION; GENE EXPRESSION REGULATION; GENETICS; METABOLISM; NEOPLASM; PHYSIOLOGY; REVIEW;

ANIMALS; CELL MOVEMENT; DNA-BINDING PROTEINS; GENE EXPRESSION REGULATION; HELIX-LOOP-HELIX MOTIFS; HYPOXIA-INDUCIBLE FACTOR 1; INFLAMMATION; ISCHEMIA; NEOPLASMS; NUCLEAR PROTEINS; TRANSCRIPTION FACTORS;

EID: 3843052715     PISSN: 15384101     EISSN: 15514005     Source Type: Journal    
DOI: None     Document Type: Editorial

References (18)

1. Semenza GL. Targeting HIF-1 for cancer therapy. Nat Rev Cancer 2003; 3:721-73.
2. Giaccia A, Siim BG, Johnson RS. HIF-1 as a target for drug development. Nat Rev Drug Discov 2003; 2:803-11.
3. Pugh CW, Ratcliffe PJ. Regulation of angiogenesis by hypoxia: Role of the HIF system. Nat Med 2003; 9:677-84.
4. Wang GL, Jiang BH, Rue EA, Semenza GL. Hvpoxia-inducible factor 1 is a basic-helix-loop-helix-PAS heterodimer regulated by cellular O2 tension. Proc Natl Acad Sci USA 1995; 92:5510-4.
5. Maxwell P. HIF-1's relationship to oxygen; simple yet sophisticated. Cell Cycle 2004; 3:156-9.
6. Peyssonaux C, Johnson RS. An unexpected role for hypoxic response: Oxygenation and inflammation. Cell Cycle 2004; 3:168-71.
7. Melillo G, Musso T, Sica A, Taylor LS, Cox GW, Varesio L. A hypoxia-responsive element mediates a novel pathway of activation of the inducible nitric oxide synthase promoter. J Exp Med 1995; 182:1683-93.
8. Cramer T, Johnson RS. A novel role for the hypoxia inducible transcription factor HIF-1alpha: Critical regulation of inflammatory cell function. Cell 2003; 2:192-193.
9. Sutphin PD, Chan DA, Giaccia AJ. Dead cells don't form tumors: HIF-dependent cytotoxins. Cell Cycle 2004; 3:160-3.
10. Potter C, Harris AL. Hypoxia inducible carbonic anhydrase IX, marker of tumor hypoxia, survival pathway adn tehrapy taregt. Cell Cycle 2004; 3:164-7.
11. Rapisarda A, Shoemaker RH, Melillo G. Targeteing topoisomerase I to inhibit hypoxia inducible factor 1. Cell Cycle 2004; 3:172-5.
12. Maxwell PH, Dachs GU, Gleadle JM, Nicholls LG, Harris AL, Stratford IJ, Hankinson O, Pugh CW, Ratcliffe PJ. Hypoxia-inducible factor-1 modulates gene expression in solid tumors and influences both angiogenesis and tumor growth. Proc Natl Acad Sci USA 1997; 94:8104-9.
13. Blouw B, Song H, Tihan T, Bosze J, Ferrara N, Gerber HP, Johnson RS, Bergers G. The hypoxic response of tumors is dependent on their microenvironment. Cancer Cell 2003; 4:133-46.
14. Krishnamachary B, Berg-Dixon S, Kelly B, Agani F, Feldser D, Ferreira G, Iyer N, LaRusch J, Pak B, Taghavi P, Semenza GL. Regulation of colon carcinoma cell invasion by hypoxia-inducible factor 1. Cancer Res 2003; 63:1138-43.
15. Pennacchietti S, Michieli P, Galluzzo M, Mazzone M, Giordano S, Comoglio PM. Hypoxia promotes invasive growth by transcriptional activation of the met protooncogene. Cancer Cell 2003; 3:347-61.
16. Schioppa T, Uranchimeg B, Saccani A, Biswas SK, Doni A, Rapisarda A, Bernasconi S, Saccani S, Nebuloni M, Vago L, Mantovani A, Melillo G, Sica A. Regulation of the chemokine receptor CXCR4 by hypoxia. J Exp Med 2003; 198:1391-402.
17. Staller P, Sulitkova J, Lisztwan J, Moch H, Oakeley EJ, Krek W. Chemokine receptor CXCR4 downregulated by von Hippel-Lindau tumour suppressor pVHL. Nature 2003; 425:307-11.
18. Blagosklonny MV. Hypoxia-inducible factor. Achilles' heel of antiangiogenic cancer therapy. Int J Oncol 2001; 19:257-62.